Taking the lead: Lyra Therapeutics Inc (LYRA)
With 0.95 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.26 million shares. The 52-week range on LYRA shows that it touched its highest point at $6.71 and its lowest point at $1.86 during that stretch. It currently has a 1-year price target of $12.20. Beta for […]
